Bylund S, Kobyletzki LB, Svalstedt M, Svensson Å. Prevalence and incidence of atopic dermatitis: a systematic review. Acta Derm Venereol. 2020;100:adv00160.

Article  PubMed  Google Scholar 

Parisi R, Symmons DPM, Griffiths CEM, Ashcroft DM. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013;133(2):377–85.

Article  PubMed  Google Scholar 

Cameron S, Donnelly A, Broderick C, et al. Mind and skin: exploring the links between inflammation, sleep disturbance and neurocognitive function in patients with atopic dermatitis. Allergy. 2024;79:26–36.

Article  PubMed  Google Scholar 

Gether L, Linares HPI, Kezic S, et al. Skin and systemic inflammation in adults with atopic dermatitis before and after whole-body topical betamethasone 17-valerate 0.1% or tacrolimus 0.1% treatment: a randomized controlled study. J Eur Acad Dermatol Venereol. 2025;39:308–21.

Article  PubMed  Google Scholar 

Paller A, Jaworski JC, Simpson EL, et al. Major comorbidities of atopic dermatitis: beyond allergic disorders. Am J Clin Dermatol. 2018;19:821–38.

Article  PubMed  Google Scholar 

Davis DMR, Drucker AM, Alikhan A, et al. American Academy of Dermatology guidelines: awareness of comorbidities associated with atopic dermatitis in adults. J Am Acad Dermatol. 2022;86:1335-1336.e18.

Article  PubMed  Google Scholar 

Bellinato F, Maurelli M, Geat D, Girolomoni G, Gisondi P. Managing the patient with psoriasis and metabolic comorbidities. Am J Clin Dermatol. 2024;25(4):527–40.

Article  PubMed  PubMed Central  Google Scholar 

Van Beugen S, Schut C, Kupfer J, et al. Perceived stigmatization among dermatological outpatients compared with controls: an observational multicentre study in 17 European countries. Acta Derm Venereol. 2023;103:adv6485.

Article  PubMed  Google Scholar 

Silverberg JI, Gelfand JM, Margolis DJ, et al. Patient burden and quality of life in atopic dermatitis in US adults: a population-based cross-sectional study. Ann Allergy Asthma Immunol. 2018;121:340–7.

Article  PubMed  Google Scholar 

Puig L, Thom H, Mollon P, Tian H, Ramakrishna GS. Clear or almost clear skin improves the quality of life in patients with moderate-to-severe psoriasis: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2017;31:213–20.

Article  PubMed  Google Scholar 

Bewley A, van de Kerkhof P. Engaging psoriasis patients in adherence and outcomes to topical treatments: a summary from the Symposium “Tailoring topical psoriasis treatments to patients” needs and expectations’ of the 30th EADV Congress 2021. J Eur Acad Dermatol Venereol. 2023;37(Suppl 1):9–13.

Article  PubMed  Google Scholar 

Bieber T. Disease modification in inflammatory skin disorders: opportunities and challenges. Nat Rev Drug Discov. 2023;22:662–80.

Article  PubMed  Google Scholar 

Lebwohl M, Langley RG, Paul C, et al. Evolution of patient perceptions of psoriatic disease: results from the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) survey. Dermatol Ther (Heidelb). 2022;12:61–78.

Article  PubMed  Google Scholar 

Kromer C, Peitsch WK, Herr R, et al. Behandlungspräferenzen für Biologika bei Psoriasis: erfahrene Patienten legen Wert auf Nachhaltigkeit. J Dtsch Dermatol Ges. 2017;15:189–201.

PubMed  Google Scholar 

Ameen M, Alhusayen R, Brandi H, et al. Patient preferences in the treatment of moderate-to-severe atopic dermatitis. Acta Derm Venereol. 2024;104:adv24339.

Article  PubMed  Google Scholar 

Müller S, Maintz L, Bieber T. Treatment of atopic dermatitis: recently approved drugs and advanced clinical development programs. Allergy. 2024;79:1501–15.

Article  PubMed  Google Scholar 

Guttman-Yassky E, Renert-Yuval Y, Brunner PM. Atopic dermatitis. Lancet. 2025;405:583–96.

Article  PubMed  Google Scholar 

Yi RC, Akbik M, Smith LR, Klionsky Y, Feldman SR. Therapeutic advancements in psoriasis and psoriatic arthritis. J Clin Med. 2025;14:1312.

Article  PubMed  PubMed Central  Google Scholar 

Drucker AM, Walwyn C, Chu C, et al. Living network meta-analysis to compare nemolizumab against other available targeted systemic treatments for atopic dermatitis. Br J Dermatol. 2025;193:548–52.

Article  PubMed  PubMed Central  Google Scholar 

Ferris LK, Bagel J, Huang Y-H, et al. FRONTIER-2: a phase 2b, long-term extension, dose-ranging study of oral JNJ-77242113 for the treatment of moderate-to-severe plaque psoriasis. J Am Acad Dermatol. 2025;92:495–502.

Article  PubMed  Google Scholar 

Chiricozzi A, Levi A, Palladino C, Girolomoni G. Enabling precision medicine with biomarkers of response to treatment in atopic dermatitis: where are we now? A narrative review. Front Med (Lausanne). 2025;12:1574697.

Article  PubMed  Google Scholar 

Mortlock RD, Ma EC, Cohen JM, Damsky W. Assessment of treatment-relevant immune biomarkers in psoriasis and atopic dermatitis: toward personalized medicine in dermatology. J Investig Dermatol. 2023;143:1412–22.

Article  PubMed  Google Scholar 

Degli Esposti L, Perrone V, Dovizio M, et al. Estimation of patients with psoriasis potentially eligible and currently untreated with biological drugs in Italy. Ital J Dermatol Venereol. 2023;158:445–51.

Article  Google Scholar 

Heratizadeh A, Mempel M, Kiedrowski R, et al. Checklist identification of candidates for systemic therapy in adult patients with atopic dermatitis in Germany: a multicentre study. J Eur Acad Dermatol Venereol. 2024;38:157–66.

Article  PubMed  Google Scholar 

Augustin M, Garbe C, Neitemeier S, et al. Regionale Variationen in der Versorgung von Patienten mit Psoriasis und atopischer Dermatitis in Deutschland. Hautarzt. 2022;73:27–39.

Article  PubMed  Google Scholar 

Von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453–7.

Article  PubMed  Google Scholar 

Cheung HN, Chan YS, Hsiung NH. Validation of the 5-D itch scale in three ethnic groups and exploring optimal cutoff values using the itch numerical rating scale. Biomed Res Int. 2021;2021:7640314.

Article  PubMed  PubMed Central  Google Scholar 

Boonstra AM, Stewart RE, Köke AJA, et al. Cut-off points for mild, moderate, and severe pain on the numeric rating scale for pain in patients with chronic musculoskeletal pain: variability and influence of sex and catastrophizing. Front Psychol. 2016;7:1466.

Article  PubMed  PubMed Central  Google Scholar 

Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210–6.

Article  PubMed  Google Scholar 

Chopra R, Vakharia PP, Sacotte R, et al. Severity strata for eczema area and severity index (EASI), modified EASI, scoring atopic dermatitis (SCORAD), objective SCORAD, atopic dermatitis severity index and body surface area in adolescents and adults with atopic dermatitis. Br J Dermatol. 2017;177:1316–21.

Article  PubMed  Google Scholar 

Nast A, Altenburg A, Augustin M, et al. German S3-guideline on the treatment of Psoriasis vulgaris, adapted from EuroGuiDerm—part 1: treatment goals and treatment recommendations. JDDG J Dtsch Dermatol Ges. 2021;19:934–150.

PubMed  Google Scholar 

Herzig M, vom Hove M, Bertsche A, et al. Medication-related perceptions of children and adolescents with severe asthma and moderate-to-severe atopic dermatitis: a non-interventional exploratory study. Allergy Asthma Clin Immunol. 2025;21:16.

Article  PubMed  PubMed Central  Google Scholar 

Zheng Y, Ding R-L, Bu J. Effectiveness and safety of systemic therapy for moderate-to-severe atopic dermatitis in children and adolescent patients: a systematic review. Front Immunol. 2024;15:1367099.

Article  PubMed  PubMed Central  Google Scholar 

Cushman DM, Kobayashi JK, Wheelwright JC, et al. Prospective evaluation of pain flares and time until pain relief following musculoskeletal corticosteroid injections. Sports Health. 2023;15:227–33.

Article  PubMed  Google Scholar 

Megna M, Battista T, Noto M, et al. Injections site reactions and biologics for psoriasis: a questionnaire based real life study. Clin Cosmet Investig Dermatol. 2023;16:553–64.

Article